| Ytd | -49.34% | |
| 1y | -54.22% |
| Open | 46.40 | Prev Close | 46.84 | Low | 46.10 | High | 48.96 | Mkt Cap | 70.00B |
| Vol | 18.86M | Avg Vol | 20.17M | EPS | 2.55 | P/E | 18.94 | Forward P/E | 14.07 |
| Beta | 0.57 | Short Ratio | 1.40 | Inst. Own | 94.94% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 10-28 | 50-d Avg | 46.63 | 200-d Avg | 67.87 | 1yr Est | 62.69 |
Boston Scientific (BSX) reported earnings 30 days ago. What's next for the stock?
AU, APTV and BSX have been added to the Zacks Rank #5 (Strong Sell) List on August 28th, 2026.
On Aug. 26, 2026, a cyberattack halted order processing and shipping at the medical device maker, le
Boston Scientific's stock is sliding in the wake of a major cyberattack, adding to its recent woes.
A cyberattack on U.S. medical device maker Boston Scientific is causing an ongoing “global disruptio
On Tuesday, Boston Scientific Corporation (NYSE:BSX) identified a cybersecurity incident on Tuesday
Boston Scientific reports a cyber incident disrupting global operations, limiting system access and
Boston Scientific said its global operations were disrupted by a "cybersecurity incident." The compa
Nasdaq 100 falls 0.6% as traders wait on Nvidia and hot July PCE revives September rate-hike bets. E
Boston Scientific stock falls as the medical device maker announces the latest batch of bad news for
Boston Scientific was hit with a cyberattack that is affecting its operations, the company said Wedn
Boston Scientific said on Wednesday that a cybersecurity incident had disrupted global operations,
On August 25, 2026, Boston Scientific Corporation (the "Company") identified a cybersecurity
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
TD Cowen analyst Joshua Jennings reiterates Boston Scientific (NYSE:BSX) with a Buy and maintains
Callan Family Office LLC bought a new position in shares of Boston Scientific Corporation (NYSE: BSX
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Asahi Life Asset Management CO. LTD. bought a new position in Boston Scientific Corporation (NYSE: B
Aurora Investment Counsel bought a new position in Boston Scientific Corporation (NYSE: BSX) in the
Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 1.54% on an annua
Boston Scientific has corrected sharply due to EP and WATCHMAN slowdowns, but 74% of its portfolio c
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations
B. Riley Wealth Advisors Inc. reduced its stake in Boston Scientific Corporation (NYSE: BSX) by 56.1
E. Ohman J or Asset Management AB cut its holdings in Boston Scientific Corporation (NYSE: BSX) by 9
Boston Scientific has been heavily sold off, now trading at attractive valuations versus peers after
The 2,100 shares were acquired for ~$100,000 on August 5, 2026. This transaction represents a 14% in
Michael F. Mahoney deployed ~$10.0 million on August 3, 2026, to acquire ~200,000 shares at a weight
UBS analyst Patrick Wood maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price t
Citigroup analyst Joanne Wuensch maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the
RBC Capital analyst Kendall Au maintains Boston Scientific (NYSE:BSX) with a Outperform and lower
TD Cowen analyst Joshua Jennings maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the
Canaccord Genuity analyst William Plovanic maintains Boston Scientific (NYSE:BSX) with a Buy and
Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and
Evercore ISI Group analyst Vijay Kumar maintains Boston Scientific (NYSE:BSX) with a Outperform a
Wells Fargo analyst Larry Biegelsen maintains Boston Scientific (NYSE:BSX) with a Equal-Weight an
BTIG analyst Marie Thibault maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the pric
Boston Scientific beat second-quarter estimates but lowered its 2026 sales and earnings outlook as r
Boston Scientific (NYSE:BSX) is looking for Q3 Adj EPS of $0.80-$0.82 vs $0.83 analyst estimate. see
Boston Scientific (NYSE:BSX) lowers FY2026 Adj EPS guidance from $3.34-$3.41 to $3.28-$3.32 vs $3.36
Boston Scientific (NYSE:BSX) reported quarterly earnings of $0.86 per share which beat the analyst c
Boston Scientific (NYSE:BSX) has outperformed the market over the past 15 years by 1.23% on an annua
Oppenheimer analyst Suraj Kalia maintains Boston Scientific (NYSE:BSX) with a Outperform and lowe
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Truist Securities analyst Richard Newitter maintains Boston Scientific (NYSE:BSX) with a Buy and
Mizuho analyst Anthony Petrone maintains Boston Scientific (NYSE:BSX) with a Outperform and lower
RBC Capital analyst Shagun Singh maintains Boston Scientific (NYSE:BSX) with a Outperform and low
July brings a sharp rotation trade in markets as investors shift from top performers to beaten-down
Needham analyst Mike Matson maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the pric
Evercore ISI Group analyst Vijay Kumar maintains Boston Scientific (NYSE:BSX) with a Outperform a
Stifel analyst Rick Wise maintains Boston Scientific (NYSE:BSX) with a Buy and lowers the price t